Embecta (EMBC) Income from Continuing Operations (2020 - 2026)
Embecta (EMBC) reported Income from Continuing Operations of 4100000.0 for Q1 2026, down 117.45% on a YoY basis from 23500000.0 in Q1 2025, and down 109.3% sequentially from 44100000.0 in Q4 2025.
Embecta (EMBC) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Income from Continuing Operations data on file, last reported at 4100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 117.45% year-over-year to 4100000.0; the trailing twelve-month figure through Mar 2026 stood at 111900000.0 (up 111.93% YoY), and the FY2025 full-year result was 95400000.0, up 21.84% from the prior year.
- Income from Continuing Operations declined to 4100000.0 in Q1 2026, from 44100000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 79600000.0 in Q1 2022 to a low of 17200000.0 in Q3 2022.
- A 5-year average of 25556250.0 and a median of 21800000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations slumped 117.75% in 2022 and soared 209.52% in 2025, its largest moves.
- Tracing EMBC's Income from Continuing Operations over 5 years: stood at 35200000.0 in 2022, then slumped by 42.9% to 20100000.0 in 2023, then retreated by 27.36% to 14600000.0 in 2024, then surged by 202.05% to 44100000.0 in 2025, then sank by 109.3% to 4100000.0 in 2026.
- Business Quant data shows EMBC's Income from Continuing Operations at 4100000.0 in Q1 2026, 44100000.0 in Q4 2025, and 26400000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | -4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.10 Mn |
| Dec 31, 2025 | 44.10 Mn |
| Sep 30, 2025 | 26.40 Mn |
| Jun 30, 2025 | 45.50 Mn |
| Mar 31, 2025 | 23.50 Mn |
| Sep 30, 2024 | 14.60 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 20.10 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 15.20 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 35.20 Mn |
| Sep 30, 2022 | -17.20 Mn |
| Jun 30, 2022 | 62.40 Mn |
| Mar 31, 2022 | 79.60 Mn |
| Dec 31, 2021 | 98.80 Mn |
| Sep 30, 2021 | 96.90 Mn |
| Jun 30, 2021 | 104.70 Mn |
| Mar 31, 2021 | 107.90 Mn |